Bat rabies is an emerging problem in North America. It's different from other rabies viruses: It seems able to reach the brain much more quickly than other strains of rabies, and it takes less virus to initiate the brain infection. In many cases of bat rabies infection, there is no known route of exposure.
The researchers, led by Bernhard Dietzschold, DVM, professor of microbiology and immunology and Matthias Schnell, Ph.D., associate professor and acting chair of biochemistry and molecular pharmacology, both at Jefferson Medical College of Thomas Jefferson University in Philadelphia, analyzed which rabies virus genes from a silver-haired bat might play a role in the virus's ability to infect the brain. To do so, they built the first molecular clone of a rabies "street" virus, akin to the virus found in the wild. They then exchanged the genes of the silver-haired bat rabies virus clone with those of a strain used in a rabies wildlife vaccine and discovered that certain parts particularly the glycoprotein cover on the virus surface are responsible for the virus's superior ability to attack the brain. They reported their findings this month online in the Proceedings of the National Academy of Sciences.
According to Dr. Dietzschold, the glycoprotein is involved in the uptake of virus by the cell receptor. He notes that the uptake of the silver-haired bat rabies virus is five times faster than other types of rabies virus from other species, which, he says, might account for its ability to infect the brain so rapidly. They reported their findings online in November in the Proceedings of the National Academy of Sciences.
"We also found that the expression of viral genes and proteins the replication of the virus is extremely regulated," he says, which differs from other species.
"The virus ev